NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fizimed

Fizimed

Private
StrasbourgHealthcare & Life Scienceshttps://emy.fizimed.com/en-us

Last Round

Series A

Mar 13, 2025

Total Funding Raised

$5.06M

Company Overview

Fizimed is a health technology company that develops and markets connected medical devices for women's health, including pelvic floor trainers and breast pumps.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

pelvic floor trainerbiofeedback deviceurinary incontinencekegel trainerfemtechconnected medical devicepelvic floor rehabilitationhealth IoTdigital healthwomen's healthhome-based therapykegel exercisesmedical hardwaretelehealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fizimed Comparables

Compare Fizimed with similar companies based on industry and business-model similarity.

Fizimed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perifit
89%
Bloom
78%
Willow Innovations, Inc.
78%

Fizimed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 13, 2025
VC RoundOct 10, 2019
SeedJan 1, 2018

Key People

Founding team and executive leadership

Allan MABILAIS

CTO - Co-founder

Founding Team

Julien Guay

CPO & co-founder

Founding Team

Emeline HAHN

CEO And co-founder

Founding Team

Fizimed Investors

Notable investors and investment history

Fizimed investors
InvestorRounds
BpifranceSeed, VC Round
Capital Grand EstSeed, Series A, VC Round
UI InvestissementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 33% MoM to 57.4K.

  • Mar 13, 2025

    $4.3M round led by Fonds Patient Autonome 1.

Fizimed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fizimed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fizimed's valuation, stock price, and market status.

Firmographic Details

HeadquartersStrasbourg
Employee Range26
Year Founded2017
Last FundingMar 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.